At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Bioequivalence of Empagliflozin/Metformin Fixed Dose Combination Tablets Compared to Single Tablets Administered Together in Healthy Male and Female Volunteers Under Fed and Fasted Conditions (an Open-label, Randomised, Single-dose, Crossover Study)
In Brief
A Phase 1 clinical trial evaluating Empagliflozin, Metformin, and 1 other intervention for Healthy. Completed, enrolled 48 participants across 1 site.
Detailed Summary
Bioequivalence of an empagliflozin/metformin (FDC) tablet compared with single tablets of two strength of empagliflozin and metformin (Part I) under fasted and under fed conditions and bioequivalence of empagliflozin/metformin (FDC) tablet compared with single tablets empagliflozin and metformin under fed conditions (Part II).
Study Details
Timeline
Interventions
medium dose oral administration
oral administration
low dose of Empagliflozin oral administration
low dose of Empagliflozin
oral administration
medium dose of Empagliflozin oral administration
medium dose oral administration
oral administration
medium dose of Empagliflozin oral administration